Respiratory Syncytial Virus

Common cold coronavirus incidence decreased by more than half after widespread SARS-CoV-2 infections and vaccination compared with pre-pandemic rates, researchers determined through a recent study.

SAN DIEGO — In 2024, administration of the four FDA-approved RSV vaccinations was low, ranging from 0.27% to 0.58%, according to a poster presented here.

CHICAGO — Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, specifically HF hospitalization and stroke, according to new research.

In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of Belgium, Italy, Spain, the Netherlands and the U.K., according to results published in The Lancet Respiratory Medicine.

The FDA is adding a warning about Guillain-Barré syndrome to the respiratory syncytial virus vaccines manufactured by GSK and Pfizer based on data that suggest there may be a link between the shots and the rare disorder.

The bivalent respiratory syncytial virus prefusion F, or RSVpreF, vaccine may prevent one hospitalization or ED visit tied to the infection for every 250 vaccinated older adults, an analysis showed.

An FDA advisory committee said it wants to see more data to understand the implications of what the FDA called an “imbalance” in cases of severe respiratory syncytial virus among infants participating in an early-stage RSV vaccine trial.

Nirsevimab and the maternal vaccine for respiratory syncytial virus can reduce health care costs and productivity losses associated with RSV but lead to higher overall spending, according to analyses published in Pediatrics.